News

Cala Receives FDA Clearance for Next-Generation kIQ Plus Wearable Device for Essential Tremor and Parkinson's Disease

FDA · 2 min

FDA Approves RAPIBLYK (Landiolol) for Pediatric Supraventricular Tachycardia - AOP Health US Expands Critical Care Treatment Options

FDA · 3 min

ASCO 2026: GI Innovation's GI-101A Phase 1 Data Preview

oncology · 2 min

FDA Approves SleepWell: New Non-Habit Forming Treatment for Chronic Insomnia

FDA · Chronic Insomnia · 7 min

FDA Approval NanoPharm Therapy: Accelerated OK for Metastatic Breast Cancer

FDA · Metastatic breast cancer · 8 min

FDA Approves FluGuard+ Vaccine: Enhanced Protection Against Emerging Flu

FDA · Influenza · 7 min

FDA Approves CardioDetect: First AI Diagnostic Tool for Arrhythmia

FDA · Cardiology · 9 min

Psoriasis Treatment Pipeline Explodes: 90+ Companies Race to Develop Next-Generation Therapies in 2026

2 min

MeiraGTx to Present 3-Year AAV-hAQP1 Gene Therapy Data for Radiation-Induced Xerostomia Treatment

2 min

Corbus Pharmaceuticals CRB-913 Obesity Drug Completes Patient Enrollment in CANYON-1 Phase 1b Trial

3 min

Actuate Therapeutics' Elraglusib Doubles Pancreatic Cancer Survival Rates in Nature Medicine Study

Metastatic Pancreatic Cancer · 3 min

DuPont Launches AmberChrom XT SL Chromatography Resins to Streamline Biopharmaceutical Manufacturing

2 min